Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascend Partners is a healthcare-focused private equity firm rather than a drug-development biotech or pharmaceutical company. The firm was founded in 2019 to invest in growth-oriented, patient-focused healthcare businesses, with an emphasis on improving access, affordability, and quality of care for underserved and vulnerable communities. Its activity appears concentrated in healthcare services, care delivery, physician practice enablement, and related operating platforms rather than therapeutic R&D. Publicly described investments include Allied Physicians Group, Adjuvant.Health, and other healthcare services assets. Because the requested name was "Ascend Capital," the closest health-related match appears to be Ascend Partners/Ascend Capital Partners, but this is not an exact name match.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascend Capital.